Metraipolis › archive › dc_2f14298e34ff

The Implementation of Faricimab in East Lancashire NHS Trust: Highlighting the Real-World Efficacy and Safety in Patients With Neovascular Age-Related Macular… — Europe PMC PMID:41170269

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41170269
DOI
10.7759/cureus.93478
License (as archived)
solo-consultazione
Archived
2026-11-09T16:39:36.386Z
SHA-256 of the archived text
c9fce9ff25a225f6f8d09023c66cec2587c3cccfcfc24a40d7e92cb741c75060
Stable URL of this page
https://metraipolis.com/documento/dc_2f14298e34ff

How to cite

The Implementation of Faricimab in East Lancashire NHS Trust: Highlighting the Real-World Efficacy and Safety in Patients With Neovascular Age-Related Macular… — Europe PMC PMID:41170269 — Europe PMC (en), https://europepmc.org/article/MED/41170269 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f14298e34ff (Metraipolis archive dc_2f14298e34ff, sha256 c9fce9ff25a225f6f8d09023c66cec2587c3cccfcfc24a40d7e92cb741c75060)
BibTeX
@misc{dc2f14298e34ff,
  title = {The Implementation of Faricimab in East Lancashire NHS Trust: Highlighting the Real-World Efficacy and Safety in Patients With Neovascular Age-Related Macular… — Europe PMC PMID:41170269},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41170269},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f14298e34ff; sha256 c9fce9ff25a225f6f8d09023c66cec2587c3cccfcfc24a40d7e92cb741c75060},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41170269. Agents can read the archived copy with the MCP tool read_document.